Find results that contain all of your keywords. Content filter is on. Search will return best illustrations, stock vectors and clipart.
Make it so!
You have chosen to exclude "" from your results.

Choose orientation:
Explore cartoons & images using related keywords:

antibody

antigen

arthritis

autoimmune

bcell

biological

biosimilar

 biotech biotechnology blood blymphocyte cancer cd20 cell chronic disease drug idiopathic immunoglobulin immunology infusion injection inn leukemia lupus lymphocytic lymphoma mab malignant monoclonal multiple nomenclature nonhodgkin pemphigus peptide protein purpura rheumatoid rituximab sclerosis thrombocytopenic transplant vulgaris white

Rituximab Monoclonal Antibody Drug. Targets CD20 On B-lymphocytes. Indications For Use Indicate Rheumatoid Arthritis And A Number Royalty-Free Stock Photo


Rituximab monoclonal antibody drug. Targets CD20 on B-lymphocytes. Indications for use indicate rheumatoid arthritis and a number Stock Photo
Download
Designed by
Title
Rituximab monoclonal antibody drug. Targets CD20 on B-lymphocytes. Indications for use indicate rheumatoid arthritis and a number #186810711
Description

Rituximab monoclonal antibody drug. Targets CD20 on B-lymphocytes. Indications for use indicate rheumatoid arthritis and a number of leukemias and lymphomas. Generic name and stylized antibody representation

IgG1 monoclonal antibody (immunoglobulin). Play essential role i
IgG1 monoclonal antibody (immunoglobulin). Play essential role i
B-lymphocyte antigen CD20 (theoretical model). Protein expressed on the surface of B-cells. Anti-CD20 monoclonal antibody drugs
B-lymphocyte antigen CD20 (theoretical model). Protein expressed on the surface of B-cells. Anti-CD20 monoclonal antibody drugs
B-lymphocyte antigen CD20 (theoretical model). Protein expressed on the surface of B-cells. Anti-CD20 monoclonal antibody drugs

B-lymphocyte antigen CD20 epitope peptide fragment, bound to rituximab (Fab fragment). Indications for rituximab include leukemia
B-lymphocyte antigen CD20 (theoretical model). Protein expressed on the surface of B-cells. Anti-CD20 monoclonal antibody drugs

B-lymphocyte antigen CD20 (theoretical model). Protein expressed on the surface of B-cells. Anti-CD20 monoclonal antibody drugs
B-lymphocyte antigen CD20 epitope peptide fragment, bound to rituximab (Fab fragment). Indications for rituximab include leukemia

B-lymphocyte antigen CD20 epitope peptide fragment, bound to rituximab (Fab fragment). Indications for rituximab include leukemia
B-lymphocyte antigen CD20 epitope peptide fragment, bound to rituximab (Fab fragment). Indications for rituximab include leukemia
B-lymphocyte antigen CD20 epitope peptide fragment, bound to rituximab (Fab fragment). Indications for rituximab include leukemia
B-lymphocyte antigen CD20 epitope peptide fragment, bound to rituximab (Fab fragment). Indications for rituximab include leukemia
IgG1 monoclonal antibody (immunoglobulin), 3D rendering. Many biotech drugs are antibodies. Atoms are shown as color-coded spheres